Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review

[1]  M. Shinohara,et al.  Usefulness of multidisciplinary care to prevent worsening renal function in chronic kidney disease , 2018, Clinical and Experimental Nephrology.

[2]  Y. Tian,et al.  Pharmaceutical Care in Kidney Transplant Recipients: Behavioral and Physiologic Outcomes at 12 Months. , 2018, Transplantation proceedings.

[3]  U. V. Mateti,et al.  Cost-effectiveness of pharmaceutical care on patients undergoing maintenance hemodialysis – a multicenter randomized controlled study , 2018, Postgraduate medicine.

[4]  Sherine Ismail,et al.  Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing , 2018, Pharmacy.

[5]  U. V. Mateti,et al.  Impact of pharmaceutical care on clinical outcomes among hemodialysis patients: A multicenter randomized controlled study. , 2018, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[6]  D. Chandrasekhar,et al.  Impact of Intensified Pharmaceutical Interventions in Medication Adherence in Chronic Kidney Disease Patients , 2018 .

[7]  M. Ghaleb,et al.  Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy , 2018, BMC Health Services Research.

[8]  C. Hughes,et al.  Appropriate Polypharmacy in Older People in Primary Care , 2018, Case Medical Research.

[9]  E. MacLaughlin,et al.  Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease , 2018, Pharmacotherapy.

[10]  C. Hughes,et al.  Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care , 2018, Journal of the American Geriatrics Society.

[11]  N. Rodondi,et al.  International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy , 2018, BMC Medicine.

[12]  Cynthia F Corbett,et al.  Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[13]  U. V. Mateti,et al.  Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients - A multicenter randomized controlled study. , 2017, Saudi Journal of Kidney Diseases and Transplantation.

[14]  H. Choong,et al.  Outcomes of pharmacist-provided medication review in collaborative care for adult Singaporeans receiving hemodialysis , 2017, International Journal of Clinical Pharmacy.

[15]  Angus G K McNair,et al.  The COMET Handbook: version 1.0 , 2017, Trials.

[16]  B. Wimmer,et al.  Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions , 2017, International journal of clinical practice.

[17]  C. Ukwe,et al.  Evaluation of drug therapy problems among renal patients receiving care in some tertiary hospitals in Nigeria , 2017 .

[18]  H. Ramadaniati,et al.  DRUG-RELATED PROBLEMS IN CHRONIC KIDNEYS DISEASE PATIENTS IN AN INDONESIAN HOSPITAL: DO THE PROBLEMS REALLY MATTER? , 2016 .

[19]  H. Kirchner,et al.  Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study , 2016, BMC Nephrology.

[20]  E. Foote,et al.  A pharmacy-based medication reconciliation and review program in hemodialysis patients: a prospective study , 2016, Pharmacy practice.

[21]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.

[22]  A. Albsoul-Younes,et al.  Role of clinical pharmacist in the management of blood pressure in dialysis patients , 2016, International Journal of Clinical Pharmacy.

[23]  T. Srinivas,et al.  Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. , 2015, Journal of the American Pharmacists Association.

[24]  A. Awaisu,et al.  Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature. , 2015, Research in Social and Administrative Pharmacy.

[25]  P. Gatault,et al.  Community pharmacist intervention in patients with renal impairment , 2015, International Journal of Clinical Pharmacy.

[26]  L. Holst,et al.  Use of renal risk drugs in patients with renal impairment , 2015, International Journal of Clinical Pharmacy.

[27]  A. Perzynski,et al.  A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial , 2015, BMC Nephrology.

[28]  Dave L Dixon,et al.  Collaborative Drug Therapy Management and Comprehensive Medication Management―2015 , 2015, Pharmacotherapy.

[29]  T. Shigematsu,et al.  A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy , 2015, Clinical and Experimental Nephrology.

[30]  P. Rama,et al.  EVALUATION AND PHARMACIST’S INTERVENTION FOR IMPROVING ADHERENCE AMONG RENAL FAILURE PATIENTS , 2015 .

[31]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[32]  Pingyang,et al.  Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment. , 2014, European journal of internal medicine.

[33]  Stuart J. Beatty,et al.  Pharmacist‐Driven Renal Medication Dosing Intervention in a Primary Care Patient‐Centered Medical Home , 2014, Pharmacotherapy.

[34]  M. Sanjurjo-Sáez,et al.  Intervenciones farmacéuticas en las prescripciones de pacientes ingresados con insuficiencia renal crónica , 2014 .

[35]  Pasquale Esposito,et al.  Clinical audit, a valuable tool to improve quality of care: General methodology and applications in nephrology. , 2014, World journal of nephrology.

[36]  G. Peterson,et al.  Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities , 2014, Drugs & Aging.

[37]  D. Ahern,et al.  Enhancing patient engagement and blood pressure management for renal transplant recipients via home electronic monitoring and web-enabled collaborative care. , 2014, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[38]  J. Gascón-Cánovas,et al.  Effectiveness of pharmacist intervention in patients with chronic kidney disease , 2014, International Journal of Clinical Pharmacy.

[39]  K. Eckardt,et al.  Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  S. Billups,et al.  Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization. , 2014, Journal of managed care & specialty pharmacy.

[41]  Saiping Jiang,et al.  Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study , 2014, Therapeutics and clinical risk management.

[42]  Saiping Jiang,et al.  Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit , 2013, Scandinavian journal of infectious diseases.

[43]  R. Moles,et al.  Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic Kidney Disease , 2013, The Annals of pharmacotherapy.

[44]  Vanitha Rani.  IMPACT OF CLINICAL PHARMACIST PROVIDED EDUCATION ON MEDICATION KNOWLEDGE AND ADHERENCE OF HEMODIALYSIS PATIENTS IN A SOUTH INDIAN UNIVERSITY HOSPITAL , 2013 .

[45]  A. Farshchi,et al.  Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency , 2013, The International journal of pharmacy practice.

[46]  A. Jarab,et al.  Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan , 2013, International Journal of Clinical Pharmacy.

[47]  M. A. Via-Sosa,et al.  Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment — a comparative study , 2013, BMC Family Practice.

[48]  T. Salgado,et al.  A Tool to Characterize the Components of Pharmacist Interventions in Clinical Pharmacy Services: The DEPICT Project , 2013, The Annals of pharmacotherapy.

[49]  Chen Li.  A Preliminary Review of the Medication Management Service Conducted by Pharmacists in Haemodialysis Patients of Singapore General Hospital , 2013 .

[50]  Chengye Chengye Li Li.  A Preliminary Review of the Medication Management Service Conducted by Pharmacists in Haemodialysis Patients of Singapore General Hospital , 2013 .

[51]  Sara Schroter,et al.  Quality of descriptions of treatments: a review of published randomised controlled trials , 2012, BMJ Open.

[52]  H. Khalili,et al.  The role of clinical pharmacy services in achieving treatment targets in Iranian haemodialysis patients. , 2012, Singapore medical journal.

[53]  Kenneth J. Smith,et al.  Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  B. Allenet,et al.  Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. , 2012, Journal of nephrology.

[55]  C. van Weel,et al.  A pharmacy medication alert system based on renal function in older patients. , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.

[56]  B. Allenet,et al.  Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010. , 2012, Journal of nephrology.

[57]  H. Mahboobi,et al.  Designing, Conducting and Reporting Randomised Controlled Trials: A Few Key Points , 2012 .

[58]  Y. Kitamura,et al.  Effect of pharmacist management on serum hemoglobin levels with renal anemia in hemodialysis outpatients. , 2011, Biological & pharmaceutical bulletin.

[59]  M. Shetty,et al.  Prevalence of medication‐related problems among patients with renal compromise in an Indian hospital , 2011, Journal of clinical pharmacy and therapeutics.

[60]  Rod J. Rohrich,et al.  The Levels of Evidence and Their Role in Evidence-Based Medicine , 2011, Plastic and reconstructive surgery.

[61]  V. Santschi,et al.  Impact of collaborative and multidisciplinary care on management of hypertension in chronic kidney disease outpatients , 2011 .

[62]  G. Vessal,et al.  Detection of prescription errors by a unit-based clinical pharmacist in a nephrology ward , 2010, Pharmacy World & Science.

[63]  H. Khalili,et al.  Clinical pharmacy services in an Iranian teaching hospital: a descriptive study , 2009, Pharmacy World & Science.

[64]  S. Jackson,et al.  Attitudes of Australian pharmacists towards practice‐based research , 2009, Journal of clinical pharmacy and therapeutics.

[65]  G. Booth,et al.  Pharmacist-led structured care for patients with diabetic nephropathy , 2008 .

[66]  T. Einarson,et al.  Hypertenion: Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management , 2007, The Annals of pharmacotherapy.

[67]  T. Einarson,et al.  Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management , 2007, The Annals of pharmacotherapy.

[68]  J. Dipiro,et al.  Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications , 2001, Clinical transplantation.

[69]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[70]  C. Kozma,et al.  Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. , 1993, Clinical therapeutics.

[71]  A. Donabedian,et al.  The quality of care. How can it be assessed? , 1988, JAMA.

[72]  M. Durán-García,et al.  Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure. , 2014, Nefrología.

[73]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Foreword , 2013 .

[74]  R. Moles,et al.  Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[75]  H. Khalili,et al.  The use of pharmaceutical care to improve health-related quality of life in hemodialysis patients in Iran , 2012, International Journal of Clinical Pharmacy.

[76]  N. Mason,et al.  Strategies for Reducing Polypharmacy and Other Medication‐Related Problems in Chronic Kidney Disease , 2010, Seminars in dialysis.

[77]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[78]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[79]  R. Schrier.  International Society of Nephrology. , 1999, Kidney International.

[80]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.